Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of LUNG Stereotactic Adaptive Ablative Radiotherapy for Central and Ultracentral Tumors

NCT04917224 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT04917224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04917224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of LUNG Stereotactic Adaptive Ablative Radiotherapy for Central and Ultracentral Tumors
Lead sponsor
Baptist Health South Florida
Phase
Not applicable
Overall status
Withdrawn
Start date
May 2, 2022
Completion date
October 1, 2032
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung tumor